Clinical Trial

Effects of Lifestyle Intervention on Childhood Outcomes in LGA Infants

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated February 5, 2021 (before its estimated November 30, 2023 completion). Its status may not reflect the trial's current state.
Summary
Large-for-gestational-age (LGA) infants have a higher risk of metabolic disease later in life, and their postnatal growth in early childhood may be associated with long-term adverse outcomes. The purpose of this study is to explore whether comprehensive lifestyle intervention in the first year after birth in LGA infants will reduce the rate of overweight/obesity at childhood and improve neurodevelopmental outcomes and its possible mechanism.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2020-12-08.
Status change: Not Yet Recruiting → Recruiting 2021-02-02
Trial Details
NCT Number NCT04661449
Lead Sponsor Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
Conditions Childhood Overweight
Enrollment 138 participants
Start Date 2021-01-22
Primary Completion 2023-11-30 (estimated)
Study Completion 2029-11-30 (estimated)
Updated on ClinicalTrials.gov 2021-02-05